Denbaars Steven sold $346K of ALMU
Denbaars Steven sold 25,000 shares of Aeluma, Inc. (ALMU) at an average of $13.83 ($13.82–$13.84, $0.35M total) across 2 trades over 2026-08-26 to 2026-08-27.
How this was made
The 30-second read
Why it matters
A director's sale may prompt short‑term traders to consider selling pressure, but the retained holdings mitigate concerns.
Market read
Insider sale of $346K is a modest but noteworthy event for a micro‑cap biotech.
What to watch
The director retains a sizable stake, indicating continued confidence.
Background
Form 4 filings disclose insider transactions; investors monitor them for potential signals.
Ticker impact
Director Steven Denbaars sold 25,000 shares for $345,741, reducing his stake to 345,209 shares.
Possible modest downside pressure in the next few days.
A $346K sale by a director is material for a micro‑cap, but the amount is modest relative to market cap.
Market effects
Minimal impact on the broader biotech sector.
Limited to U.S. investors tracking insider activity.
None
Counterpoint
The sale could be a routine liquidity event, not a negative signal.
Key entities
- CompanyAeluma, Inc.
Biotech firm listed on NASDAQ under ticker ALMU.
- InsiderSteven Denbaars
Director of Aeluma who sold shares.
